Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts

Breaking Down Biosimilar Insulins: A Look at ...

Up next

Digital Innovation in Diabetes Prevention for Older Adults

Host: Steve Jackson, PharmD Guest: Souptik Barua, PhD Guest: Emily Johnston, MPH, PhD Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Ds. Emily Johnston an ...  Show more

Incretin-Based Advances in Obesity and T2D Care

Guest: Javier Morales, MD, FACP, FACE For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Mor ...  Show more

Recommended Episodes

Diabetes Core Update – February 2024
Diabetes Core Update

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approxi ...

  Show more

Treating Geriatric Polypharmacy by Deintensifying Unnecessary Diabetes Treatment
JAMA Clinical Reviews

Polypharmacy is a rapidly worsening problem that hits elderly patients particularly hard.  As patients grow older, they need more medications but at the same time become less capable of managing the complexity of drug treatments.  In order to simplify treatment regimens for ol ...

  Show more

#330 Inpatient Diabetes Part 1: Insulin regimens, oral hypoglycemics, corrections scales and more!
The Curbsiders Internal Medicine Podcast

<div>Dominate inpatient diabetes! In this part 1 of 2, we discuss how to handle oral hypoglycemics, how to choose an initial insulin regimen, the use of correction scale insulin monotherapy, how to titrate insulin, how to use NPH for steroid-induced hyperglycemia (check out this ...  Show more